EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation

Lale A Ertuglu, Esteban Porrini, Mads Hornum, Atalay Demiray, Baris Afsar, Alberto Ortiz, Adrian Covic, Peter Rossing, Mehmet Kanbay iD

Transplant International · 2021-08 · 34 (8) · 1341-1359

DOI: 10.1111/tri.13883 ↗

At a glance

Übersichtsarbeit in Transplant International, published online on 2021-06-30. Written by Lale A Ertuglu and 8 co-authors. Institution: Department of Medicine, Koc University School of Medicine, Istanbul, Turkey. Major MEDLINE topics: Diabetes Mellitus, Type 2, Organ Transplantation. Cited 22 times so far (Crossref); 120 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Post-transplant diabetes mellitus (PTDM) is a common complication of solid organ transplantation and a major cause of increased morbidity and mortality. Additionally, solid organ transplant patients may have pre-existent type 2 diabetes mellitus (T2DM). While insulin is the treatment of choice for hyperglycemia in the first weeks after transplantation, there is no preferred first line agent for long-term management of PTDM or pre-existent T2DM. Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter 2 (SGLT2) inhibitors improve glycemic control, lower body weight, and blood pressure, are recommended after lifestyle and metformin as initial therapy for diabetic patients with cardiovascular or kidney comorbidities regarding their cardiorenal benefits. Furthermore, the mechanisms of action of GLP-1RA may counteract some of the driving forces for PTDM, as calcineurin-induced β cell toxicity as per preclinical data, and improve obesity. However, their use in the treatment of PTDM is currently limited by a paucity of data. Retrospective observational and small exploratory studies suggest that GLP-1RA effectively improve glycemic control and induce weight loss in patients with PTDM without interacting with commonly used immunosuppressive agents, although randomized-controlled clinical trials are required to confirm their safety and efficacy. In this narrative review, we evaluate the risk factors and pathogenesis of PTDM and compare the potential roles of GLP-1RA and SGLT2 inhibitors in PTDM prevention and management as well as in pre-existent T2DM, and providing a roadmap for evidence generation on newer antidiabetic drugs for solid organ transplantation.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Organ TransplantationGlucagon-Like Peptide-1 ReceptorGlucoseHumansHypoglycemic AgentsRetrospective StudiesSodium

Author keywords

SGLT2 inhibitorsdiabetes mellitusglucagon-like peptide-1kidney transplantationpost-transplant diabetes mellitussolid organ transplantation

Substances

Glucagon-Like Peptide-1 ReceptorHypoglycemic AgentsSodiumGlucose

Authors and institutions

  • Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
  • Red de Investigación Renal (REDINREN), Instituto Carlos III-FEDER, Tenerife, Spain.
  • Department of Medicine, Hospital Universitario de Canarias, Tenerife, Spain.
  • Instituto de Tecnologías Biomédicas, University of La Laguna, Tenerife, Spain.
  • Department of Nephrology, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID profiles: Mehmet Kanbay

Cite

APA

Ertuglu, L. A., Porrini, E., Hornum, M., Demiray, A., Afsar, B., Ortiz, A., Covic, A., Rossing, P., & Kanbay, M. (2021). Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation. Transplant International, 34(8), 1341-1359. https://doi.org/10.1111/tri.13883

Vancouver

Ertuglu LA, Porrini E, Hornum M, Demiray A, Afsar B, Ortiz A, et al. Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation. Transplant International. 2021;34(8):1341-1359. doi:10.1111/tri.13883

BibTeX
@article{Ertuglu2021,
  author = {Ertuglu, Lale A and Porrini, Esteban and Hornum, Mads and Demiray, Atalay and Afsar, Baris and Ortiz, Alberto and Covic, Adrian and Rossing, Peter and Kanbay, Mehmet},
  title = {Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation},
  journal = {Transplant International},
  year = {2021},
  volume = {34},
  number = {8},
  pages = {1341--1359},
  doi = {10.1111/tri.13883}
}
Start for free →